memorial sloan kettering symposium on lymphoma · 2016-04-25 · is pleased to announce:...
TRANSCRIPT
Is pleased to announce:
Friday-Saturday, May 13-14, 2016
Memorial Sloan Kettering Symposium on LymphomaState of the art in biology, therapy, and patient care
CONFERENCE LOCATION
MEMORIAL SLOAN KETTERING CANCER CENTERZUCKERMAN RESEARCH CENTER
NEW YORKTo register or for more information, please go to:
www.mskcc.org/lymphoma2016
www.mskcc.org/lymphoma2016
Memorial Sloan Kettering Symposium on Lymphoma
Friday-Saturday, May 13-14, 2016
State of the art in biology, therapy, and patient care
TARGET AUDIENCEMedical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in diagnosis, treatment, and biomedical research of lymphoma.
COURSE OVERVIEWThis symposium will feature updated information on lymphoma biology, diagnosis, immunology, and genetics, and ongoing efforts to translate the scientific discoveries into novel treatment strategies for a variety of lymphomas. Faculty will review the current standard of care and present their own perspectives on how they treat various types of lymphomas. Participants will have the opportunity to discuss diagnostic and management cases, and how to incorporate biologic and genetic biomarkers into clinical practice and clinical trials.
You won't want to miss this unprecedented symposium focused on the future of Lymphoma with many of
the world’s leading experts.
www.mskcc.org/lymphoma2016
Memorial Sloan Kettering Symposium on LymphomaState of the art in biology, therapy, and patient care
Friday-Saturday, May 13-14, 2016
SYMPOSIUM CHAIR
Anas Younes MD Chief, Lymphoma Service
ORGANIZING COMMITTEE
Ahmet Dogan MD PhD
Craig Moskowitz MD
Hans Guido Wendel MD
Joachim Yahalom MD FACR
Andrew Zelenetz MD PhD
Memorial Sloan Kettering Symposium on LymphomaState of the art in biology, therapy, and patient care
Friday-Saturday, May 13-14, 2016
www.mskcc.org/lymphoma2016 www.mskcc.org/lymphoma2016
MSK FACULTY GUEST FACULTY
Maria Arcila MDConnie Batlevi MD PhDJohn F. Gerecitano MD PhDPaul Hamlin MDSteven Horwitz MDAndrew M. Intlekofer MD PhDAnita Kumar MDMatthew Matasar MDAlison Moskowitz MDAriela Noy MDM. Lia Palomba MDCarol Portlock MDMikhail Roshal MDMichel Sadelain MD PhDDavid Straus MDJedd D. Wolchok MD PhD
Ranjana Advani MDStanford University
Steve Ansell MD PhDMayo Clinic
Francesco D’Amore MDAarhus University
Riccardo Dalla-Favera MDColumbia University
Martin Dreyling MDLudwig Maximilian University
Randy Gascoyne MDBC Cancer Agency
Elaine Jaffe MDNational Cancer Institute
Ronald Levy MDStanford University
Barbara Pro MDNorthwestern University
John Radford MDUniversity of Manchester
Louis Staudt MD PhDNational Cancer Institute
Gilles Salles MD PhDHospices Civils de Lyon
Wyndham Wilson MD PhDNational Cancer Institute
Thomas Witzig MDMayo Clinic
MSK conducts one of thelargest clinical researchprograms in the world,aimed at improving the
prevention, diagnosis,and treatment of cancer.
In December 2013, ourphysicians were leading
1,259 clinical researchstudies for pediatric
and adult cancers.
Friday-Saturday, May 13-14, 2016
www.mskcc.org/lymphoma2016
Memorial Sloan Kettering Symposium on LymphomaState of the art in biology, therapy, and patient care
Friday-Saturday, May 13-14, 2016
www.mskcc.org/lymphoma2016
GUEST FACULTY
Ranjana Advani MDStanford University
Steve Ansell MD PhDMayo Clinic
Francesco D’Amore MDAarhus University
Riccardo Dalla-Favera MDColumbia University
Martin Dreyling MDLudwig Maximilian University
Randy Gascoyne MDBC Cancer Agency
Elaine Jaffe MDNational Cancer Institute
Ronald Levy MDStanford University
Barbara Pro MDNorthwestern University
John Radford MDUniversity of Manchester
Louis Staudt MD PhDNational Cancer Institute
Gilles Salles MD PhDHospices Civils de Lyon
Wyndham Wilson MD PhDNational Cancer Institute
Thomas Witzig MDMayo Clinic
Friday, May 137:00-8:00am BREAKFAST & REGISTRATION
8:00-8:05am Welcoming Remarks and Introduction to the MSK Lymphoma Symposium and Grand Rounds Lecture Anas Younes MD
8:05-8:50am DEPARTMENT OF MEDICINE GRAND ROUNDS Advances in Immunotherapy of Lymphoma Ronald Levy MD
INTRODUCTION CHAIRS Anas Younes MD and Elaine Jaffe MD
9:15-9:45am LymphomaClassification Elaine Jaffe MD
9:45-10:15am Advances in Molecular Diagnostics Maria Arcila MD
10:15-10:35am Advances in Radiation Oncology Joachim Yahalom MD FACR
10:35-10:50am Survivorship Program for Patients with Lymphoma Matthew Matasar MD
10:50-11:30am State of The Lymphoma at MSK Anas Younes MD
11:30am-12:30pm LUNCH
DIFFUSE LARGE B CELL LYMPHOMA-I CHAIRS Louis Staudt MD PhD and Thomas Witzig MD
12:30-12:45pm DLBCL Overview Thomas Witzig MD
12:45-1:15pm Advances in DLBCL Biology Riccardo Dalla-Favera MD
1:15-1:45pm Mechanism-Based Therapy of Lymphoma Louis Staudt MD PhD
1:45-2:05pm Application of Genome Sequencing in Hematopathology Practice Ahmet Dogan MD PhD
2:05-2:20pm How I Treat DLBCL Andrew Zelenetz MD PhD
2:20-2:35pm How I Treat Double Hit Lymphoma Wyndham Wilson MD PhD
2:35-2:50pm How I Treat Burkitt Lymphoma Ariela Noy MD
2:50-3:15pm CLINICAL CASES CHAIRS Witzig, Zelenetz, Wilson, Hamlin, Noy, Jaffe
3:15-3:30pm BREAK
Memorial Sloan Kettering Symposium on LymphomaState of the art in biology, therapy, and patient care
Friday-Saturday, May 13-14, 2016
www.mskcc.org/lymphoma2016 www.mskcc.org/lymphoma2016
Friday, May 13HODGKIN LYMPHOMA CHAIRS John Radford MD and Craig Moskowitz MD
3:30-4:00pm HL Overview John Radford MD
4:00-4:30pm Advances in HL Biology Randy Gascoyne MD
4:30-4:45pm HL Genetics Mikhail Roshal MD
4:45-5:00pm How I Treat Newly Diagnosed HL David Straus MD
5:00-5:15pm How I Treat Relapsed HL Craig Moskowitz MD
5:15-5:30pm Novel Therapy for Hodgkin Lymphoma Alison Moskowitz MD
5:30-6:00pm CLINICAL CASESCHAIRS Radford, Moskowitz, Younes, Ansell, Straus, Yahalom, Gascoyne
6:00-7:00pm COCKTAIL RECEPTION
Friday-Saturday, May 13-14, 2016
www.mskcc.org/lymphoma2016
Memorial Sloan Kettering Symposium on LymphomaState of the art in biology, therapy, and patient care
Friday-Saturday, May 13-14, 2016
www.mskcc.org/lymphoma2016
Friday, May 13 HODGKIN LYMPHOMA
CHAIRS John Radford MD and Craig Moskowitz MD
3:00-3:30pm HL Overview John Radford MD
3:30-4:00pm Advances in HL Biology Randy Gascoyne MD
4:00-4:15pm HL Genetics Mikhail Roshal MD
4:15-4:30pm How I Treat Newly Diagnosed HL David Straus MD
4:30-4:45pm How I Treat Relapsed HL Craig Moskowitz MD
4:45-5:00pm Novel Therapy for Hodgkin Lymphoma Alison Moskowitz MD
5:00-5:30pm CLINICAL CASES CHAIRS Radford, Moskowitz, Younes, Ansell, Straus, Yahalom, Gascoyne
5:30-6:30pm COCKTAIL RECEPTION
Saturday, May 147:00-8:00am BREAKFAST
FOCUS ON IMMUNO ONCOLOGY CHAIRS Ronald Levy MD and Anas Younes MD
8:00-8:30am Overview of Immune Checkpoint Inhibitors in Cancer Jedd D. Wolchok MD PhD
8:30-9:00am Novel Immune Therapy Strategies Ronald Levy MD
9:00-9:30am Advances in CAR T cell Therapy Michel Sadelain
9:30-9:50am Immune Checkpoint Inhibitors in Lymphoma Steve Ansell MD PhD
9:50-10:10am NovelBispecificAntibodiesandADCs Ranjana Advani MD
10:10-10:30am Novel Immune Therapy Combinations Anas Younes MD
TRIALS IN PROGRESS CHAIRS Paul Hamlin MD and John Gerecitano MD PhD
10:30-10:40am Trials in Progress with Immune Checkpoint Inhibitors A. Moskowitz, Palomba
10:40-10:50am Trials in Progress with ADC Hamlin, Horwitz
10:50-11:00am Trials in Progress with BCL2 Inhibitors Zelenetz, Gerecitano
11:00-11:10am Trials in Progress with PI3K Inhibitors Horwitz, Gerecitano
11:10-11:20am Trials with Biomarker Selection (CREBBP IDH2, EZH2,MDM2) Intlekofer, Batlevi
11:20-11:30am Trials in Progress with BCR Signaling Inhibitors Noy, Hamlin
11:30-11:45am BREAK
Memorial Sloan Kettering Symposium on LymphomaState of the art in biology, therapy, and patient care
Friday-Saturday, May 13-14, 2016
www.mskcc.org/lymphoma2016
Saturday, May 14T CELL LYMPHOMA CHAIRS F. D’Amore and S. Horwitz
11:45am-12:15pm T Cell Lymphoma Overview Francesco D’Amore MD
12:15-12:30pm How I Treat Newly Diagnosed PTCL Steven Horwitz MD
12:30-12:45pm How I Treat Patients with Relapsed T Cell Lymphoma Barbara Pro MD
12:45-1:00pm CLINICAL CASESCHAIRS Horwitz, D’Amore, Pro, Advani, Yahalom, Jaffe, Dogan
1:00-2:00pm LUNCH
MANTLE CELL AND FOLLICULAR LYMPHOMA CHAIRS Martin Dreyling MD and Gilles Salles MD PhD
2:00-2:30pm MCL Overview Martin Dreyling MD
2:30-3:00pm How I Treat MCL Paul Hamlin MD
3:00-3:30pm Follicular Lymphoma Overview Gilles Salles MD
3:30-4:00pm Insights into Follicular Lymphoma Biology Hans Guido Wendel MD
4:00-4:30pm EpigeneticModifiersinthePathogenesisofFollicular Lymphoma Laura Pasqualucci MD
4:30-5:00pm How I Treat Newly Diagnosed Indolent Lymphoma Carol Portlock MD
5:00-5:15pm How I Treat Waldenstrom Macroglobulinemia M. Lia Palomba MD
5:15-5:45pm CLINICAL CASESCHAIRS Dreyling, Salles, Portlock, Gascoyne, Dogan
5:45pm CLOSING REMARKSAnas Younes MD
Friday-Saturday, May 13-14, 2016
www.mskcc.org/lymphoma2016
Saturday, May 14 T CELL LYMPHOMA
CHAIRS F. D’Amore and S. Horwitz
11:45am-12:15pm T Cell Lymphoma Overview Francesco D’Amore MD
12:15-12:30pm How I Treat Newly Diagnosed PTCL Steven Horwitz MD
12:30-12:45pm How I Treat Patients with Relapsed T Cell Lymphoma Barbara Pro MD
12:45-1:00pm CLINICAL CASES CHAIRS Horwitz, D’Amore, Pro, Advani, Yahalom, Jaffe, Dogan
1:00-2:00pm LUNCH
MANTLE CELL AND FOLLICULAR LYMPHOMA CHAIRS Martin Dreyling MD and Gilles Salles MD PhD
2:00-2:30pm MCL Overview Martin Dreyling MD
2:30-3:00pm How I Treat MCL Paul Hamlin MD
3:00-3:30pm Follicular Lymphoma Overview Gilles Salles MD
3:30-4:00pm Insights into Follicular Lymphoma Biology Hans Guido Wendel MD
4:00-4:30pm EpigeneticModifiersinthePathogenesisofFollicular Lymphoma Laura Pasqualucci MD
4:30-5:00pm How I Treat Newly Diagnosed Indolent Lymphoma Carol Portlock MD
5:00-5:15pm How I Treat Waldenstrom Macroglobulinemia M. Lia Palomba MD
5:15-5:45pm CLINICAL CASES CHAIRS Dreyling, Salles, Portlock, Gascoyne, Dogan
5:45pm CLOSING REMARKS Anas Younes MD
REGISTRATION
$400 MDs, PhDs, DOs
$280 MSK Alliance and MSK Alumni
$200 Nurses, PAs, and other Healthcare Professionals
$100 Residents and Fellows
Registration includes continental breakfast, lunch, and refreshment breaks. Special meals are available upon request, including vegetarian, kosher, or gluten-free. Please let us know if we can assist you with any special dietary needs.
To register, please go to:
www.mskcc.org/lymphoma2016The registration fee is waived for all MSK staff. However, you must register for the course by visiting the Continuing Medical Education page on OneMSK
OFFICE OF CONTINUING MEDICAL EDUCATIONMemorial Sloan Kettering Cancer Center633ThirdAvenue,12thfloor,NewYork,[email protected]
COURSE DESIGN
This symposium includes hands-on review of cases which will be intermixed with short didactic lectures. One workstation per participant.
EVALUATION
A course evaluation survey sent out electronically will provide attendees with the opportunity to review the sessions and the speakers and to identify future educational needs.
ACCREDITATION STATEMENT
MSK is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA CREDIT DESIGNATION STATEMENT
MSK designates this live activity for a maximum of 17.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The AMA has determined that physicians not licensed in the United States but who participate in this CME activity are eligible for 17.25 AMA PRA Category 1 Credits™.
OUTCOMES MEASUREMENT SURVEY
Six months after the end of the course an Outcomes Measurement Survey will be sent to all participants to help us determine what positive impacts have been made on participant practice as a result of the course.
FACULTY DISCLOSURE
It is the policy of MSK to make every effort to insure balance, independence, objectivity,andscientificrigorinallcontinuing medical education activities which it sponsors as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity sponsored by MSK are expected todiscloseanysignificantfinancialinterest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.
ACCOMMODATIONS
If you are traveling to MSK from outof town, we recommend that youreserve hotel rooms as early aspossible. To make the planning a littleeasier, MSK has negotiated rates atselect hotels in Manhattan. For a list of these hotels, please go to:www.mskcc.org/accommodations.